Skip to search.
 FTSE 100 Up 0.24%

More On AUXL

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Auxilium Pharmaceuticals, Inc. (AUXL)

-NasdaqGS
36.47 0.00(0.00%) 29 Jan 21:00
Add to Portfolio
Prev Close:36.47
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:32.65
Beta:-0.29
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:17.10 - 37.92
Volume:0
Avg Vol (3m):1,238,680
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-2.98
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AUXL 0.00%N/A
ABTDown 0.29%72.91b
ACTDown 0.99%119.64b
LLYDown 1.13%75.92b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products for urology and sexual health worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback